Chemical formula: C₃₃H₄₂O₁₉ Molecular mass: 742.675 g/mol PubChem compound: 5486699
Data on a limited number of exposed pregnancies indicate no adverse effects of O-(beta-hydroxyethyl)-rutosides on pregnancy or on the health of the fetus/new-born child. Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal/fetal development, parturition or postnatal development.
Nevertheless, according to generally accepted safety recommendations, HR should not be used during the first three months of pregnancy.
In animal studies, traces of HR were found in the fetuses and in the milk of breastfeeding dams. These minor amounts of HR are of no clinical significance.
Animal studies did not indicate effects on fertility following administration of O-(beta-hydroxyethyl)-rutosides.
Troxerutin has no or negligible influence on the ability to drive and use machines. In rare instances tiredness and dizziness have been reported in patients using this product. If affected, patients are advised not to drive or operate machines.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
